Rightway vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 53)
Rightway logo

Rightway

ChallengerHealthcare

Care Navigation & Pharmacy Benefits Management

Rightway is the most transparent PBM and care navigation platform for employers; delivers 16.1% lower pharmacy costs and 15% medical cost savings; launched 2025 rebrand as integrated PBM + care navigation leader.

AI VisibilityBeta
Overall Score
C53
Category Rank
#225 of 596
AI Consensus
87%
Trend
stable
Per Platform
ChatGPT
57
Perplexity
54
Gemini
51

About

Rightway is a healthcare benefits company that combines Pharmacy Benefits Management (PBM) and personalized care navigation in a single integrated platform for self-insured employers. Founded in 2017 and headquartered in New York City, Rightway positions itself as the most transparent and member-focused PBM in the market — operating on fully aligned, pass-through pricing with a 100% transparency model and a total pharmacy spend guarantee that traditional PBMs do not offer. The company launched a significant 2025 rebrand marking its evolution from challenger to category leader.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

53
Overall Score
90
#225
Category Rank
#2
87
AI Consensus
83
stable
Trend
stable
57
ChatGPT
92
54
Perplexity
93
51
Gemini
89
54
Claude
96
54
Grok
95

Key Details

Category
Care Navigation & Pharmacy Benefits Management
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.